Steve Brozak Stock Analyst Profile - WBB Securities Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Steve Brozak

    Stock Analyst at WBB Securities

    (1.69)
    # 3381
    Out of 5,506 analysts
    18
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Drug Manufacturers - Specialty & Generic

    8 Stocks

    Name Action PT Current % Upside Ratings Updated
    CDTX Cidara Therapeutics
    Reiterates: Strong Buy
    123 123
    		101.99 20.6% 4 Sep 24, 2025
    CELU Celularity
    Upgrades: Buy
    6 6
    		2.13 181.69% 2 Sep 9, 2025
    MRKR Marker Therapeutics
    Reiterates: Strong Buy
    13 13
    		0.95 1215.79% 1 Apr 1, 2025
    CFRX ContraFect
    Upgrades: Strong Buy
    560
    		n/a n/a 3 Jun 8, 2022
    PRTK Paratek Pharmaceutic...
    Upgrades: Strong Buy
    11
    		n/a n/a 2 Feb 10, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    150
    		n/a n/a 2 Aug 11, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Strong Buy
    75 100
    		4.58 2083.41% 1 Jun 18, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Buy
    17000 16000
    		1.9 842005.26% 3 May 28, 2021